• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

ForSight Vision

Forsight Vision6 drums up another $3m

September 22, 2017 By Brad Perriello

The sixth company to come out ophthalmology incubator ForSight Labs said today that it raised $3.0 million from a syndicate of nine unnamed investors. Stealthy ForSight Vision6 revealed the equity round in a regulatory filing today. The company added $3.0 million in December 2014 to the $1 million is raised in 20153 from a lone backer. […]

Filed Under: Funding Roundup, Optical/Ophthalmic, Wall Street Beat Tagged With: ForSight Vision

Allergan picks up ForSight Vision for $95m

August 11, 2016 By Fink Densford

Allergan (NYSE: AGN) said today it inked a deal to buy drug-eluting ophthalmological implant maker ForSight Vision5 for $95 million up front, with a possible milestone payment for launching its drug-eluting device. Pharmaceutical giant Allergan said the device, known as the Helios ring, is designed for extended drug delivery and for reducing intraocular pressure in […]

Filed Under: Business/Financial News, Mergers & Acquisitions, Optical/Ophthalmic Tagged With: Allergan, ForSight Vision

ForSight Vision5’s Helios implant delivers at 6 months in Phase II trial

May 5, 2016 By Brad Perriello

The Helios drug-eluting implant developed by ForSight Vision5 lowered intraocular pressure in glaucoma patients by about 20% after 6 months, according to study results published today in Ophthalmology, the journal of the American Academy of Ophthalmology. The Helios device is a thin, silicone ring impregnated with the glaucoma drug bimatoprost that’s designed to slowly release the drug […]

Filed Under: Clinical Trials, Optical/Ophthalmic Tagged With: ForSight Vision, Glaucoma

ForSight Vision5 adds another $8m

October 19, 2015 By Brad Perriello

ForSight Vision5, which is developing devices to treat front-of-the-eye conditions such as glaucoma and dry eye disease, said today that it raised another $7.8 million. ForSight Vision5 is a spinout of ForSight Labs, a Menlo Park, Calif.-based incubator focused on developing ophthalmic treatments. Last year the company reeled in a $15 million Series C round. […]

Filed Under: Funding Roundup, Optical/Ophthalmic Tagged With: ForSight Vision

Stealthy ForSight Vision6 raises another $3m

December 12, 2014 By Brad Perriello Leave a Comment

YYmeta

The 6th company to come out ophthalmology incubator ForSight Labs said this month that it raised $3.0 million from a syndicate of 5 unnamed investors.

Stealthy ForSight Vision6 revealed the equity round in a Dec. 6 regulatory filing.

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic Tagged With: ForSight Vision

GI Dynamics raises $32M in private placement with group overseas | Medtech funding stories for the week of May 5, 2014

May 9, 2014 By MassDevice Leave a Comment

Weight loss: GI Dynamics raises $32M with private placement

May 2, 2014 by Brad Perriello

Weight loss: GI Dynamics raises $32M with private placement

Filed Under: Funding Roundup, News Well Tagged With: EarLens, endogastricsolutions, Fire1, ForSight Vision, GI Dynamics, Lightstone Ventures

ForSight moves on to VISION6 with $6M equity funding round

May 6, 2014 By Arezu Sarvestani Leave a Comment

ForSight moves on to Vision6 with $6M equity funding round

California ophthalmic incubator ForSight Labs is seeking $6 million in order to fund its VISION6 project, the latest in a string of developments spun out of the company.

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic Tagged With: ForSight Vision

ForSight Vision5 pulls down a $15 million Series C round | Medtech funding stories for the week of Apr. 21, 2014

April 25, 2014 By MassDevice Leave a Comment

ForSight Vision5 lands $15M Series C round

April 18, 2014 by Brad Perriello

ForSight Vision5 lands $15M Series C round

Filed Under: Funding Roundup, News Well Tagged With: Baxano Surgical, Cerapedics Inc., ForSight Vision, GE Healthcare, National Venture Capital Assn. (NVCA), PricewaterhouseCoopers (PwC), Sotera Wireless, Thomson Reuters

ForSight Vision5 lands $15M Series C round

April 18, 2014 By Brad Perriello Leave a Comment

ForSight Vision5 lands $15M Series C round

ForSight Vision5, which is developing devices to treat front-of-the-eye conditions such as glaucoma and dry eye disease, said it pulled down a $15 million Series C round.

ForSight Vision5 is a spinout of ForSight Labs, a Menlo Park, Calif.-based incubator focused on developing ophthalmic treatments.

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic Tagged With: ForSight Vision, Venture Capital/Private Equity

ForSight Vision5 gets new CEO, closes $9.3M funding round

June 17, 2013 By Brian Johnson Leave a Comment

ForSight logo

ForSight Vision5, an early-stage ophthalmology company based in Silicon Valley, named venture capitalist and medtech veteran John Maroney as its new chief executive.

Filed Under: Funding Roundup, News Well, Optical/Ophthalmic Tagged With: Delphi Ventures, ForSight Vision, Personnel Moves, Technology Partners

Wright Medical announces $200M debt offering | Wall Street Beat

August 22, 2012 By MassDevice staff Leave a Comment

MassDevice.com Wall Street Beat

Wright Medical (NSDQ:WMGI) said it’s planning a private placement for $200 million worth of senior notes due 2017.

Filed Under: News Well, Wall Street Beat Tagged With: Angeion Corp., Debt Financing, ForSight Vision, MGC Diagnostics, Morgenthaler Ventures, Penrith Corp., Qualcomm, Siemens, Telcare Inc., wrightmedical

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS